Integrated Diagnostics Holdings plc
IDGXF
$0.4591
-$0.009-1.92%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 135.95M | 128.68M | 127.67M | 129.73M | 134.76M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 135.95M | 128.68M | 127.67M | 129.73M | 134.76M |
| Cost of Revenue | 80.79M | 77.87M | 79.14M | 81.37M | 83.83M |
| Gross Profit | 55.16M | 50.81M | 48.53M | 48.36M | 50.93M |
| SG&A Expenses | 22.59M | 22.61M | 22.60M | 23.65M | 24.37M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -1.45M | -1.28M | -941.40K | -791.60K | -202.10K |
| Total Operating Expenses | 101.93M | 99.19M | 100.79M | 104.22M | 108.00M |
| Operating Income | 34.02M | 29.48M | 26.87M | 25.50M | 26.76M |
| Income Before Tax | 33.45M | 28.26M | 33.85M | 31.21M | 32.35M |
| Income Tax Expenses | 11.35M | 10.18M | 9.74M | 9.82M | 10.69M |
| Earnings from Continuing Operations | 22.10 | 18.08 | 24.11 | 21.39 | 21.66 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -16.50K | 906.60K | 1.57M | 2.29M | 2.14M |
| Net Income | 22.09M | 18.99M | 25.68M | 23.68M | 23.80M |
| EBIT | 34.02M | 29.48M | 26.87M | 25.50M | 26.76M |
| EBITDA | 40.33M | 35.91M | 33.74M | 33.01M | 34.79M |
| EPS Basic | 0.04 | 0.03 | 0.04 | 0.04 | 0.04 |
| Normalized Basic EPS | 0.04 | 0.03 | 0.04 | 0.04 | 0.04 |
| EPS Diluted | 0.04 | 0.03 | 0.04 | 0.04 | 0.04 |
| Normalized Diluted EPS | 0.04 | 0.03 | 0.04 | 0.04 | 0.04 |
| Average Basic Shares Outstanding | 2.34B | 2.36B | 2.37B | 2.39B | 2.40B |
| Average Diluted Shares Outstanding | 2.34B | 2.36B | 2.37B | 2.39B | 2.40B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 0.22% | 0.13% | -- | -- | -- |